Ordinary Index Rebalancing in the Solactive Diabetes Performance-Index | March 2020

In the ordinary rebalance the following composition will be implemented:

ABBOTT LABORATORIES
APPLIED THERAPEUTICS INC
CONVATEC GROUP PLC
DEXCOM INC
ELI LILLY & CO
INSULET CORP
KALVISTA PHARMACEUTICALS INC
LEXICON PHARMACEUTICALS INC
Livongo Health Inc
MANNKIND CORP
NOVO NORDISK A/S
PDL BIOPHARMA INC
POXEL SA
PROVENTION BIO INC
SENSEONICS HOLDINGS INC
TANDEM DIABETES CARE INC
VTV THERAPEUTICS INC- CL A
YPSOMED HOLDING AG
ZEALAND PHARMA A/S